Felix W. Frueh
- Molecular Biology top 10%
- Pharmacology top 0.5%
- Genetics top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Economics and Econometrics top 5%
- Co-authors
- Federico GoodsaidRobert S. EpsteinRonald E. AubertShashi AmurLawrence J. LeskoEric J. StanekDavid GurwitzBarnabie Agatep
- Topics
- Pharmacogenetics and Drug Metabolism (21 papers)Health Systems, Economic Evaluations, Quality of Life (13 papers)Statistical Methods in Clinical Trials (13 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Felix W. Frueh
50 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 799
- Pharmacology 654
- Genetics 369
- Pediatrics, Perinatology and Child Health 299
- Economics and Econometrics 210
Countries citing papers authored by Felix W. Frueh
This map shows the geographic impact of Felix W. Frueh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix W. Frueh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix W. Frueh more than expected).
Fields of papers citing papers by Felix W. Frueh
This network shows the impact of papers produced by Felix W. Frueh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix W. Frueh. The network helps show where Felix W. Frueh may publish in the future.
Co-authorship network of co-authors of Felix W. Frueh
This figure shows the co-authorship network connecting the top 25 collaborators of Felix W. Frueh. A scholar is included among the top collaborators of Felix W. Frueh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix W. Frueh. Felix W. Frueh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 35 | |
| 3 | 2 | |
| 4 | 319 | |
| 5 | 6 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 21 | |
| 9 | 22 | |
| 10 | 26 | |
| 11 | 93 | |
| 12 | 9 | |
| 13 | 7 | |
| 14 | 24 | |
| 15 | 28 | |
| 16 | 39 | |
| 17 | 27 | |
| 18 | 10 | |
| 19 | 54 | |
| 20 | 2 |
About Felix W. Frueh
Felix W. Frueh is a scholar working on Pharmacology, Statistics and Probability and Family Practice, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Statistical Methods in Clinical Trials (13 papers). The work is most often cited by research in Pharmacology (654 citations), Statistics and Probability (165 citations) and Pediatrics, Perinatology and Child Health (299 citations). Felix W. Frueh has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Federico Goodsaid, Robert S. Epstein, Ronald E. Aubert, Shashi Amur, Lawrence J. Lesko, Eric J. Stanek, David Gurwitz, Barnabie Agatep, Christopher Sanders and R Verbrugge. Their work appears in journals such as Journal of the American Chemical Society, Circulation and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.